Please assess the completion status of the following clinical trial:

Trial Title: Examination of the Effects of Liraglutide on the Mode of Action of Insulin Detemir

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed with type 2 diabetes~* BMI less than 45.0 kg/m2~* Insulin naive~* Currently treated with Oral Anti-Diabetic drugs (OADs) and metformin with a HbA1c between 7.0 and 9.5% or currently treated with metformin only with a HbA1c between 7.0 and 10.0%~Exclusion Criteria:~* Any clinically significant disease other than type 2 diabetes~* Currently using daily insulin~* Thiazolidinione use or other injectable diabetes medications within the last 3 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).